

ARA-290
ARA-290 is an 11-amino-acid peptide derived from the helix B region of erythropoietin.
It was designed to engage the innate repair receptor — a heteromeric complex of the EPO receptor and the beta-common receptor — without the erythropoietic activity of the parent hormone. That separation is precisely why it is studied: it allows researchers to isolate tissue-protective receptor signaling from red-cell effects in preclinical models.
- Compound class
- Synthetic research compound
- Research category
- Recovery & Structural
- SKU
- NVR-ARA-290-10MG
- Appearance
- Lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
More detail on ARA-290.
Analytical values reflect per-lot documentation and appear once a batch is released.
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
ARA-290 is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.
Related research materials


BPC-157 / TB-500 Blend
2 strengths available
Combined preparation of two structural-research peptides for parallel cytoskeletal and signaling studies.
Up to 28% lower per mg
